Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

316 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Amsacrine combined with etoposide and methylprednisolone is a feasible and safe component in first-line intensified treatment of pediatric patients with high-risk acute lymphoblastic leukemia in CoALL08-09 trial.
Mezger K, Ebert S, Muhle HE, Stadt UZ, Borkhardt A, Dilloo D, Faber J, Feuchtinger T, Imschweiler T, Jorch N, Pekrun A, Schmid I, Schramm F, Zimmermann M, Horstmann MA, Escherich G. Mezger K, et al. Among authors: ebert s. Pediatr Blood Cancer. 2022 Dec;69(12):e29997. doi: 10.1002/pbc.29997. Epub 2022 Sep 21. Pediatr Blood Cancer. 2022. PMID: 36129234
Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study.
Michels N, Boer JM, Enshaei A, Sutton R, Heyman M, Ebert S, Fiocco M, de Groot-Kruseman HA, van der Velden VHJ, Barbany G, Escherich G, Vora A, Trahair T, Dalla-Pozza L, Pieters R, Zur Stadt U, Schmiegelow K, Moorman AV, Zwaan CM, den Boer ML. Michels N, et al. Among authors: ebert s. Lancet Haematol. 2021 Oct;8(10):e700-e710. doi: 10.1016/S2352-3026(21)00272-6. Lancet Haematol. 2021. PMID: 34560013 Free PMC article.
Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias.
Mark C, Meshinchi S, Joyce B, Gibson B, Harrison C, Bergmann AK, Goemans BF, Pronk CJH, Lapillonne H, Leverger G, Antoniou E, Schneider M, Attarbaschi A, Dworzak M, Stary J, Tomizawa D, Ebert S, Lejman M, Kolb EA, Schmiegelow K, Hasle H, Abla O. Mark C, et al. Among authors: ebert s. Br J Haematol. 2024 Feb;204(2):576-584. doi: 10.1111/bjh.19067. Epub 2023 Sep 24. Br J Haematol. 2024. PMID: 37743097
Contribution of laboratory medicine and emerging technologies to cardiovascular risk reduction via exposome analysis: an opinion of the IFCC Division on Emerging Technologies.
Gruson D, Fux E, Kemaloğlu Öz T, Gouget B, Lee W, Shah S, Liu Y, Ebert S, Greaves R, Bernardini S, Yang HS, Figueroa Montes L. Gruson D, et al. Among authors: ebert s. Clin Chem Lab Med. 2024 Sep 2. doi: 10.1515/cclm-2024-0788. Online ahead of print. Clin Chem Lab Med. 2024. PMID: 39238286 Free article.
Making MS Omics Data ML-Ready: SpeCollate Protocols.
Tariq MU, Ebert S, Saeed F. Tariq MU, et al. Among authors: ebert s. Methods Mol Biol. 2024;2836:135-155. doi: 10.1007/978-1-0716-4007-4_9. Methods Mol Biol. 2024. PMID: 38995540
316 results